Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020)
Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang
bioRxiv, 2020
SNFG,
Text,
Oxford
taxonomy (1)
protein (2)
source (2)
structure (0)
composition (165)
disease (1)
reference (1)
site (32)
peptide (83)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
Source
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- HexNAc:1 dHex:1 (avg mass : 367.3533 )
- HexNAc:1 dHex:2 (avg mass : 513.4963 )
- HexNAc:2 (avg mass : 424.4053 )
- HexNAc:2 dHex:1 (avg mass : 570.5483 )
- HexNAc:2 dHex:2 (avg mass : 716.6913 )
- Hex:1 HexNAc:2 (avg mass : 586.5477 )
- Hex:1 HexNAc:2 dHex:1 (avg mass : 732.6907 )
- Hex:1 HexNAc:2 dHex:2 (avg mass : 878.8337 )
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:2 HexNAc:2 dHex:2 (avg mass : 1040.9761 )
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:2 dHex:2 (avg mass : 1203.1185 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:3 dHex:2 (avg mass : 1406.3135 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 NeuAc:1 (avg mass : 1608.4804 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 1957.8184 )
- Hex:3 HexNAc:6 (avg mass : 1723.6125 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:3 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2161.0134 )
- Hex:3 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2452.2713 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:3 HexNAc:7 dHex:1 (avg mass : 2072.9505 )
- Hex:3 HexNAc:8 (avg mass : 2130.0025 )
- Hex:3 HexNAc:8 dHex:1 (avg mass : 2276.1455 )
- Hex:3 HexNAc:9 (avg mass : 2333.1975 )
- Hex:3 HexNAc:9 dHex:1 (avg mass : 2479.3405 )
- Hex:4 HexNAc:2 (avg mass : 1072.9749 )
- Hex:4 HexNAc:2 dHex:1 (avg mass : 1219.1179 )
- Hex:4 HexNAc:2 dHex:2 (avg mass : 1365.2609 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:3 dHex:2 (avg mass : 1568.4559 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 NeuAc:1 (avg mass : 1973.8178 )
- Hex:4 HexNAc:5 NeuAc:2 (avg mass : 2265.0757 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2411.2187 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:4 HexNAc:6 NeuAc:1 (avg mass : 2177.0128 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:7 (avg mass : 2088.9499 )
- Hex:4 HexNAc:7 dHex:1 (avg mass : 2235.0929 )
- Hex:4 HexNAc:8 (avg mass : 2292.1449 )
- Hex:4 HexNAc:9
- Hex:4 HexNAc:9 dHex:1 (avg mass : 2641.4829 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:2 dHex:1 (avg mass : 1381.2603 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 NeuAc:2 (avg mass : 2427.2181 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:5 HexNAc:6 (avg mass : 2047.8973 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2776.5561 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3067.814 )
- Hex:5 HexNAc:8 dHex:1 (avg mass : 2600.4303 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:3 NeuAc:1 (avg mass : 1891.7126 )
- Hex:6 HexNAc:3 dHex:1 (avg mass : 1746.5977 )
- Hex:6 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 2037.8556 )
- Hex:6 HexNAc:4 (avg mass : 1803.6497 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:1 (avg mass : 2501.2976 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2647.4406 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3229.9564 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:6 HexNAc:7 dHex:1 (avg mass : 2559.3777 )
- Hex:6 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 3724.4093 )
- Hex:6 HexNAc:9
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:4 (avg mass : 1965.7921 )
- Hex:7 HexNAc:4 NeuAc:1 (avg mass : 2257.05 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:5 (avg mass : 2168.9871 )
- Hex:7 HexNAc:5 dHex:1 (avg mass : 2315.1301 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2606.388 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2897.6459 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 NeuAc:1 (avg mass : 2663.44 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2809.583 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:4 NeuAc:2
- Hex:7 HexNAc:6 dHex:5 NeuAc:4
- Hex:7 HexNAc:7 dHex:1 (avg mass : 2721.5201 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:2 (avg mass : 3304.0359 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:3 (avg mass : 3595.2938 )
- Hex:7 HexNAc:7 dHex:1 NeuAc:4
- Hex:7 HexNAc:8
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:8 HexNAc:5 (avg mass : 2331.1295 )
- Hex:8 HexNAc:6 NeuAc:1 (avg mass : 2825.5824 )
- Hex:8 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2971.7254 )
- Hex:8 HexNAc:7 (avg mass : 2737.5195 )
- Hex:8 HexNAc:7 NeuAc:1
- Hex:8 HexNAc:7 dHex:1 (avg mass : 2883.6625 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:1 (avg mass : 3174.9204 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:2 (avg mass : 3466.1783 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:3 (avg mass : 3757.4362 )
- Hex:8 HexNAc:7 dHex:1 NeuAc:4 (avg mass : 4048.6941 )
- Hex:8 HexNAc:8
- Hex:8 HexNAc:8 dHex:1 (avg mass : 3086.8575 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:9 HexNAc:5 dHex:1 (avg mass : 2639.4149 )
- Hex:9 HexNAc:6 (avg mass : 2696.4669 )
- Hex:9 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3425.1257 )
- Hex:9 HexNAc:8 (avg mass : 3102.8569 )
- Hex:9 HexNAc:8 dHex:1 (avg mass : 3248.9999 )
- Hex:9 HexNAc:8 dHex:1 NeuAc:3 (avg mass : 4122.7736 )
- Hex:9 HexNAc:8 dHex:1 NeuAc:4 (avg mass : 4414.0315 )
- Hex:9 HexNAc:9 dHex:1 (avg mass : 3452.1949 )
- Hex:10 HexNAc:2 (avg mass : 2045.8293 )
- Hex:10 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 3296.0102 )
- Hex:10 HexNAc:9 (avg mass : 3468.1943 )
- Hex:10 HexNAc:9 dHex:1 (avg mass : 3614.3373 )
- Hex:11 HexNAc:2 (avg mass : 2207.9717 )
- Hex:11 HexNAc:6 dHex:1 (avg mass : 3166.8947 )
Composition
- COVID-19 (DOID:0080600)
Disease
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHK (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- GWIFGTTLDSKTQSLLIVNNATNVVIK (27aa)
- TQSLLIVNNATNVVIKVCE (19aa)
- SNIIRGWIFGTTLDSKTQSLLIVNNATNVVIK (32aa)
- FQFCNDPFLGVYYHKNNKSWMESE (24aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VCEFQFCNDPFLGVYYHKNNK (21aa)
- FQFCNDPFLGVYYHKNNKSWMESEF (25aa)
- VCEFQFCNDPFLGVYYHKNNKSWMESEFR (29aa)
- VCEFQFCNDPFLGVYYHKNNKSWMESEFR (29aa)
- FQFCNDPFLGVYYHKNNKSWME (22aa)
- NNKSWMESEFR (11aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- SEFRVYSSANNCTFEYVSQPFLMDLE (26aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- FRVYSSANNCTFE (13aa)
- VYSSANNCTFEYVSQPFLMDLEGKQGNFKNLR (32aa)
- PLVDLPIGINITR (13aa)
- PLVDLPIGINITR (13aa)
- DLPQGFSALEPLVDLPIGINITR (23aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSETKCTLK (23aa)
- TFLLKYNENGTITDAVDCALDPLSE (25aa)
- NGTITDAVDCALDPLSEK (18aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- SIVRFPNITNLCPFGE (16aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- VFNATR (6aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (57aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (57aa)
- DPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (57aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (48aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- HVNNSYE (7aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- QIYKTPPIKDFGGFNFSQILPDPSKPSK (28aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSK (16aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- KNFTTAPAICHDGK (14aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- CVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPRE (61aa)
- AHFPREGVFVSNGTHWFVTQR (21aa)
- AHFPREGVFVSNGTHWFVTQR (21aa)
- KNFTTAPAICHDGKAHFPRE (20aa)
- NFTTAPAICHDGKAHFPR (18aa)
- NFTTAPAICHDGK (13aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
- YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
- LNEVAKNLNESLIDLQELGK (20aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- LNEVAKNLNESLIDLQELGKYEQYIK (26aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- NLNESLIDLQE (11aa)
- VAKNLNESLIDLQE (14aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
Mass spectrometry observed peptide
-
- HexNAc:1 / N-Linked (avg mass : 221.2103)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- FPNITNLCPFGEVFNATRFASVYAWNR (27aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- KNFTTAPAICHDGK (14aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:1 dHex:1 / N-Linked (avg mass : 367.3533)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- KNFTTAPAICHDGK (14aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:1 dHex:2 / N-Linked (avg mass : 513.4963)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- KNFTTAPAICHDGK (14aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:2 dHex:1 / N-Linked (avg mass : 570.5483)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:1 HexNAc:2 / N-Linked (avg mass : 586.5477)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- VAKNLNESLIDLQE (14aa)
-
- HexNAc:2 dHex:2 / N-Linked (avg mass : 716.6913)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SEFRVYSSANNCTFE (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:1 HexNAc:2 dHex:1 / N-Linked (avg mass : 732.6907)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- GIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATR (36aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:2 HexNAc:2 / N-Linked (avg mass : 748.6901)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:1 HexNAc:2 dHex:2 / N-Linked (avg mass : 878.8337)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
- YFKNHTSPDVDLGDISGINASVVNIQKE (28aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:2 HexNAc:2 dHex:1 / N-Linked (avg mass : 894.8331)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- SIVRFPNITNLCPFGE (16aa)
- VFNATR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GVFVSNGTHWFVTQR (15aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:2 HexNAc:2 dHex:2 / N-Linked (avg mass : 1040.9761)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- SIVRFPNITNLCPFGE (16aa)
- VFNATR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- QIYKTPPIKDFGGFNFSQILPDPSKPSK (28aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- KNFTTAPAICHDGKAHFPRE (20aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked (avg mass : 1056.9755)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- FQFCNDPFLGVYYHKNNKSWMESE (24aa)
- FQFCNDPFLGVYYHKNNKSWME (22aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- PLVDLPIGINITR (13aa)
- PLVDLPIGINITR (13aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- SIVRFPNITNLCPFGE (16aa)
- VFNATR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- HVNNSYECDIPIGAGICASYQTQTNSPR (28aa)
- HVNNSYE (7aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- QIYKTPPIKDFGGFNFSQILPDPSKPSK (28aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- KNFTTAPAICHDGKAHFPRE (20aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
- NLNESLIDLQE (11aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:4 HexNAc:2 / N-Linked (avg mass : 1072.9749)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIKVCE (19aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VFNATR (6aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNE (7aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:3 HexNAc:2 dHex:2 / N-Linked (avg mass : 1203.1185)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- FQFCNDPFLGVYYHKNNKSWMESE (24aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- FQFCNDPFLGVYYHKNNK (18aa)
- FQFCNDPFLGVYYHKNNKSWMESEF (25aa)
- FQFCNDPFLGVYYHKNNKSWME (22aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- PLVDLPIGINITR (13aa)
- PLVDLPIGINITR (13aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSETKCTLK (23aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- SIVRFPNITNLCPFGE (16aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- VFNATR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- QIYKTPPIKDFGGFNFSQILPDPSKPSK (28aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSK (16aa)
- TPPIKDFGGFNFSQILPDPSKPSK (24aa)
- KNFTTAPAICHDGK (14aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- CVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPRE (61aa)
- KNFTTAPAICHDGKAHFPRE (20aa)
- NFTTAPAICHDGK (13aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQKEIDR (28aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- LNEVAKNLNESLIDLQELGK (20aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- LNEVAKNLNESLIDLQELGKYEQYIK (26aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- NLNESLIDLQE (11aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:4 HexNAc:2 dHex:2 / N-Linked (avg mass : 1365.2609)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:5 HexNAc:2 dHex:1 / N-Linked (avg mass : 1381.2603)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- KNFTTAPAICHDGK (14aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
-
- Hex:3 HexNAc:3 dHex:2 / N-Linked (avg mass : 1406.3135)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- TFLLKYNENGTITDAVDCALDPLSETK (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- VFNATR (6aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- HVNNSYE (7aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- LNEVAKNLNESLIDLQELGK (20aa)
- NLNESLIDLQELGK (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- IDRLNEVAKNLNE (13aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- QIYKTPPIKDFGGFNFSQILPDPSKPSK (28aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNE (7aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- SEFRVYSSANNCTFE (15aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSETK (19aa)
- NGTITDAVDCALDPLSEK (18aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VFNATR (6aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- ILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWR (51aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- TPPIKDFGGFNFSQILPDPSKPSKR (25aa)
- VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIE (39aa)
- DFGGFNFSQILPDPSKPSKR (20aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- DFGGFNFSQILPDPSK (16aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- VDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (47aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- NFTTAPAICHDGK (13aa)
- GVFVSNGTHWFVTQR (15aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:4 HexNAc:3 dHex:2 / N-Linked (avg mass : 1568.4559)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SEFRVYSSANNCTFE (15aa)
- KGIYQTSNFRVQPTESIVRFPNITNLCPFGE (31aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRR (37aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRAR (39aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGK (41aa)
- EGVFVSNGTHWFVTQR (16aa)
- EGVFVSNGTHWFVTQR (16aa)
- GYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPR (46aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQKE (33aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- YFKNHTSPDVDLGDISGINASVVNIQK (27aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NLNESLIDLQELGKYEQYIK (20aa)
- EIDRLNEVAKNLNESLIDLQELGK (24aa)
- VAKNLNESLIDLQE (14aa)
- VAKNLNE (7aa)
- IDRLNEVAKNLNESLIDLQE (20aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked (avg mass : 1625.5079)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- FPNITNLCPFGE (12aa)
- FPNITNLCPFGE (12aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (36aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- VYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPR (48aa)
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTK (33aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- SSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKR (34aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- VQPTESIVRFPNITNLCPFGEVFNATR (27aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- FPNITNLCPFGEVFNATR (18aa)
- AGCLIGAEHVNNSYE (15aa)
- AGCLIGAEHVNNSYE (15aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- NSVAYSNNSIAIPTNFTISVTTE (23aa)
- DFGGFNFSQILPDPSKPSK (19aa)
- KNFTTAPAICHDGK (14aa)
- GVFVSNGTHWFVTQR (15aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- EELDKYFKNHTSPDVDLGDISGINASVVNIQK (32aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- NHTSPDVDLGDISGINASVVNIQK (24aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- ELDKYFKNHTSPDVDLGDISGINASVVNIQKE (32aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- NHTSPDVDLGDISGINASVVNIQKE (25aa)
- VAKNLNESLIDLQE (14aa)
-
- Hex:6 HexNAc:3 dHex:1 / N-Linked (avg mass : 1746.5977)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- GWIFGTTLDSKTQSLLIVNNATNVVIK (27aa)
- TQSLLIVNNATNVVIK (16aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFE (11aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- VYSSANNCTFEYVSQPFLMDLEGK (24aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSE (17aa)
- NGTITDAVDCALDPLSEK (18aa)
- YNENGTITDAVDCALDPLSETK (22aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide